Clinical trial
Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome
NCT00424892 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00424892 |
|---|---|
| Title | Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome |
| Official title | A 6-Month Open-Label Extension Study of the Long-Term Safety of DVS SR in Outpatients With Fibromyalgia Syndrome. |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Desvenlafaxine Sustained Release |
| Enrollment | 600 |
| Completion | Jun 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Dec 6, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: